Chronic cough, defined as a cough lasting more than eight weeks, is a common yet challenging condition to manage in clinical practice. It often leads to significant morbidity, affecting patients' quality of life and causing considerable diagnostic and therapeutic dilemmas for clinicians.
Chronic cough is typically associated with three primary etiologies: asthma, gastroesophageal reflux disease (GERD), and upper airway cough syndrome (UACS). These conditions often coexist, complicating diagnosis and management. The pathophysiology of chronic cough involves a complex interplay between the cough reflex pathway and various triggers, leading to hypersensitivity and hyperresponsiveness of the cough reflex.
An effective diagnostic approach begins with a thorough clinical history and physical examination. This is followed by initial testing to rule out common causes, such as chest radiography for suspected lung disease and spirometry for asthma. If these tests are inconclusive, further investigations may include high-resolution computed tomography, bronchoscopy, or esophageal pH monitoring for GERD. Empirical treatment trials can also provide diagnostic clues.
Management of chronic cough focuses on treating the underlying cause. For asthma, inhaled corticosteroids are first-line therapy. Proton pump inhibitors are used for GERD, and antihistamines or nasal steroids for UACS. In refractory cases, neuromodulators like gabapentin or amitriptyline can be considered to reduce cough reflex sensitivity. Patient education and reassurance are vital components of management.
Chronic cough is a complex condition requiring a comprehensive and systematic approach for effective diagnosis and management. Understanding the common etiologies, pathophysiology, and employing a stepwise diagnostic approach can aid in identifying the underlying cause. Tailoring the treatment to the identified cause, along with patient education, can significantly improve outcomes and patient satisfaction.
1.
Cancer tumor anatomy influences the benefits of chemotherapy for patients with early-stage breast cancer.
2.
FDA Investigating Blood Cancer Risk With Gene Therapy Skysona
3.
Adding Lenvatinib to Pembro Ups PFS in Head and Neck Cancer
4.
In early dementia, SSRIs enhance cognition and major depression.
5.
TCL1A Protein Identified as Predictor of Blinatumomab Response in Relapsed B-ALL
1.
Oncologic Emergencies: Diagnosis and Treatment
2.
Strategic Standards in Hematology for Specialists
3.
Emerging Chemo-Immunotherapy: New Agents and Mechanisms in Modern Oncology
4.
Advanced Breakthroughs in Hematology and Patient Outcomes
5.
Multidisciplinary Insights into Diagnosis, Management, and Outcomes in Oncology
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Navigating the Complexities of Ph Negative ALL - Part IX
2.
A Continuation to The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma
3.
Current Scenario of Cancer- An Overview of The Incidence of Cancer in Men
4.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part II
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation